American International Group, Inc. Shattuck Labs, Inc. Transaction History

American International Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.7 - $4.59 $35,658 - $60,620	-13,207 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.22 - $8.89 $3,924 - $8,267	-930 Reduced 6.58%	13,207 $56,000
Q4 2021 Feb 11, 2022	SELL	$8.36 - $21.08 $3,536 - $8,916	-423 Reduced 2.91%	14,137 $120,000
Q3 2021 Nov 12, 2021	SELL	$17.57 - $28.95 $6,061 - $9,987	-345 Reduced 2.31%	14,560 $297,000
Q2 2021 Aug 13, 2021	BUY	$24.14 - $37.68 $175,449 - $273,858	7,268 Added 95.17%	14,905 $432,000
Q1 2021 May 07, 2021	BUY	$27.92 - $52.5 $530 - $997	19 Added 0.25%	7,637 $223,000
Q4 2020 Feb 12, 2021	BUY	$19.0 - $57.61 $144,742 - $438,872	7,618 New	7,618 $399,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $50.4M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.